Publications scientifiques

Bocti, C. (29 janvier 2019). Le cerveau vieillissant et les maladies d'Alzheimer. Colloque Alzheimer. « Le pouvoir de faire la différence dans la vie des personnes atteintes ». Société Alzheimer de l'Estrie. Sherbrooke, Québec, Canada.

Fortier, M., Castellano, C.-A., Croteau, É., Langlois, F., Bocti, C., St-Pierre, V., et al. (Fülöp, T., Cunnane, S. C.) (2019). A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimer's & Dementia, 15(5), 625-634.

Tanguay Bernard, M.-M., Luc, M., Carrier, J.-D., Fournier, L., Duhoux, A., Côté, É., Lessard, O., Gibeault, C., Bocti, C., & Roberge, P. (2019). Patterns of benzodiazepines use in primary care adults with anxiety disorders. Heliyon, 4(7), e00688.

Levy, J. P., Bocti, C., Élie, D., Paquet, N., Soucy, J.-P., & Ducharme, S. (2019). Bifrontal hypermetabolism on brain FDG-PET in a case of C9orf72-related behavioral variant of frontotemporal dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 31(1), 92-94.

Rehayel, S., Bocti, C., *Sévigny-Dupont, P., Joannette, M., Lavallée, M. M., Nikelski, J., Chertkow, H., & Joubert, S. (2019). Subcortical amyloid load is associated with shape and volume in cognitively normal individuals. Human Brain Mapping, 40(13), 3951-3965.

Zukotynski, K., Gaudet, V., Kuo, P. H., Adamo, S., Goubran, M., Scott, C., Bocti, C., et al. (2019). The use of random forests to classify amyloid brain PET. Clinical Nuclear Medicine, 44(10), 784-788.

Rahayel, S., Bocti, C., *Sévigny-Dupont, P., Joannette, M., Lavallée, M. M., Nikelski, J., Chertkow, H., & Joubert, S. (2019). Subcortical amyloid relates to cortical morphology in cognitively normal individuals. European Journal of Nuclear Medicine and Molecular Imaging, 46(11), 2358-2369.

Belleville, S., LeBlanc, A. C., Kergoat, M.-J., Calon, F., Gaudreau, P., Hébert, S. S., Hudon, C., Leclerc, N., Mechawar, N., Duchesne, S., Gauthier, S., Consortium for the Early Identification of alzheiemr's disease-Quebec (CIMA-Q), et al. (Bocti, C.) (2019). The Consortium for the early identification of Alzheimers's disease-Quebec (CIMA-Q). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 11(December), 787-796.

Zykotynski, K., Gaudet, V. C., Kuo, P., Adamo, S., Goubran, M., Bocti, C., Borrie, M., Chertkow, H., et al. (2019). Non-binary approaches for classification of amyloid brain PET. Proceedings of the IEEE 49^th International Symposium on Multiple-Valued Logic (May 2019, Fredericton, NB, Canada). Institute of Electrical and Electronics Engineers. pp. 206-211.

*Legrand, D., Roberge, P., Vanasse, A., & Bocti, C. (10 mai 2019). Étude de l'association entre l'exposition aux benzodiazépines et l'apparition de troubles neurocognitifs de type Alzheimer. Journées PIVOT « Mieux vieillir ». Centre de recherche sur le vieillissement. Sherbrooke, Québec, Canada.